ALISON MORAWSKI: Open Payments
NPI 1073022851 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 33 payments from 15 companies in 2025. Trend: 2023 $338 · 2024 $510 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| TAIHO ONCOLOGY, INC. | 8 | $149 |
| TerSera Therapeutics LLC | 2 | $64 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $46 |
| Novocure Inc. | 2 | $41 |
| Eisai Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: LONSURF, Xermelo, LUTATHERA, LIBTAYO, KEYTRUDA, Optune Lua (NovoTTF-200T), Lenvima, ELAHERE.
Industry payments across NJ — which companies pay providers there.
